ASH 2014 – TB prevention and new treatments in Asia Pacific region

Written by Charlie Grieve – CEO

We recently worked on an important and challenging project on tuberculosis prevention and treatment in Asia Pacific with FHI360 and USAID – CAP-TB Control and Prevention of Tuberculosis (CAP-TB) is a five-year project funded by the U.S. Agency for International Development (USAID) to reduce the incidence and mortality from Multi-Drug Resistant TB (MDR-TB.)  The project’s overall aim is to develop a model for cost-effective MDR-TB control that can be sustainably expanded throughout Myanmar, China, and Thailand. The prime cooperating agency for the CAP-TB Project is FHI 360, with teams of professionals in each of the countries.


In 2013, an estimated 9 million people developed TB and 1.5 million died from the disease, 360 000 of whom were HIV-positive. Of these 9 million people who developed TB in 2013, more than half (56%) were in the South-East Asia and Western Pacific Regions Working with leaders in the fight against MDR-TB, we covered the 2014 Union Conference in Barcelona, interviewing a wide range of experts treating patients in communities devastated by TB and the growing healthcare ‘perfect storm’ around the rise of MDR-TB, co-infection HIV/AIDS, and a rapidly increasing problem with diabetes. With three camera crews and on-site interviewer–journalists, we filmed, edited and published over 50 interviews from the congress to multiple streaming education and news websites, and social media channels, The focus of our video coverage was in Asia Pacific countries including China, Myanmar, Thailand, Cambodia and Vietnam.



Comments are closed.


We'd love to work with you

Contact Us

16-17 Little Portland Street

+44 (0)20 7291 5070


8 Cross Street, Level 28
PWC Building
Singapore, 048424

+44 (0)20 7291 5070

Suffolk Coast

Basepoint Unit 12a
The Havens
Ransomes Euro Park
Ipswich, IP3 9BF

T. +44 (0)1473 722 794

Call Us